Evidence map›Paper›PMID 41889371›Full record

ArticleCirculation. Genomic and precision medicine2026

Structural Evaluation of

Kundivy Dauda, Kohei Yamauchi, Matthew Ku, Devyn W Mitchell, Alex Shen, Loren Vanags, Jeffrey Schmeckpeper, Prince J Kannankeril, Bjorn C Knollmann, Matthew J O'Neill and 1 more

Abstract read
In one paragraph

Article in Circulation. Genomic and precision medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Kundivy Dauda *Division of Genetic Medicine and Clinical Pharmacology, Department of Medicine (K.D., M.K., D.W.M., A.S., L.V., B.C.K., B.M.K.).ORCID 0000-0003-1360-7939
Kohei Yamauchi *Department of Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Japan (K.Y.).ORCID 0009-0004-0348-2305
Matthew Ku *Division of Genetic Medicine and Clinical Pharmacology, Department of Medicine (K.D., M.K., D.W.M., A.S., L.V., B.C.K., B.M.K.).
Devyn W MitchellDivision of Genetic Medicine and Clinical Pharmacology, Department of Medicine (K.D., M.K., D.W.M., A.S., L.V., B.C.K., B.M.K.).ORCID 0000-0001-8508-3324
Alex ShenDivision of Genetic Medicine and Clinical Pharmacology, Department of Medicine (K.D., M.K., D.W.M., A.S., L.V., B.C.K., B.M.K.).ORCID 0009-0001-8430-8357
Loren VanagsDivision of Genetic Medicine and Clinical Pharmacology, Department of Medicine (K.D., M.K., D.W.M., A.S., L.V., B.C.K., B.M.K.).ORCID 0009-0003-5950-2777
Jeffrey SchmeckpeperDivision of Cardiology, Department of Medicine (J.S.), Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0001-9437-5871
Prince J KannankerilDepartment of Pediatrics (P.J.K.), Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-1529-9872
Bjorn C KnollmannDivision of Genetic Medicine and Clinical Pharmacology, Department of Medicine (K.D., M.K., D.W.M., A.S., L.V., B.C.K., B.M.K.).ORCID 0000-0003-4956-9735
Matthew J O'NeillDepartment of Medicine, Brigham and Women's Hospital, Boston, MA (M.J.O.).
Brett M KronckeDivision of Genetic Medicine and Clinical Pharmacology, Department of Medicine (K.D., M.K., D.W.M., A.S., L.V., B.C.K., B.M.K.).ORCID 0000-0001-6215-0803

Funding

Integrating KCNH2 Variant-Specific Features and Heterozygote Phenotypes to Estimate Long QT PenetranceR01HL160863 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Brett M Kroncke · 2022 to 2026
$2.9M
Aberrant Splicing in the Cardiac ArrhythmiasF30HL163923 · NHLBI · VANDERBILT UNIVERSITY · PI O'NEILL, MATTHEW · 2022 to 2023
$61k
NHLBI NIH HHS F30 HL163923NHLBI NIH HHS R01 HL160863
6 · The paper itself

Abstract

backgroundCatecholaminergic polymorphic ventricular tachycardia (CPVT) is strongly associated with rare missense variants in

methodsWe curated 179 articles reviewed by 3 individuals to extrapolate

resultsFrom the literature, we identified 1014 affected missense

conclusionsTraditional categorical variant annotations limit accurate disease risk assessment, especially in populations unascertained for disease. A probabilistic, population-calibrated penetrance framework enables more meaningful prospective variant interpretation. Our Bayesian CPVT-prior outperforms current tools in evaluating RYR2 variant penetrance. We provide prospective Bayesian CPVT penetrance values for 29 242 RYR2 missense variants at our online variant browser.

Indexed as

Mutation, MissensePenetranceRyanodine Receptor Calcium Release ChannelTachycardia, VentricularBayes TheoremHeterozygoteHumansPolymorphic Catecholaminergic Ventricular TachycardiaRyanodine Receptor Calcium Release ChannelRyR2 protein, humancalciumcounselorsheterozygotespenetrancesarcoplasmic reticulum

Identifiers

PMID41889371
PMCPMC13108506

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.